ASAlfred Pokmeng See

Alfred Pokmeng See

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alfred Pokmeng See has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Risk factors for the development of brain injury in utero from vein of Galen malformation

    by Gabriella Orbach, Emma N. Puglisi, Steven J. Staffa, Julie Meadows, Alfred P. See, Darren B. Orbach

  • Patient and physician perspectives on large language model generated responses about brain aneurysm

    by Joon Hyeok Choi, Marcella Ruppert-Gomez, Liam M. Shanahan, Steven J. Staffa, Darren B. Orbach, Edward R. Smith, Soliman Oushy, Laura Lehman, Anna M. Larson, Shivani D. Rangwala, et al.

    Purpose Large language models (LLMs) are becoming increasingly popular in medicine and neurosurgery. Because LLMs are not trained in specific subspecialties or diagnoses, a better understanding of the implications, effectiveness, and use of LLMs by users and clinicians is necessary. To better understand LLM’s effectiveness in neurosurgery and aneurysms, we compared community and physician feedback on ChatGPT 4o and Gemini 1.5 Flash responses to frequently asked questions regarding brain aneurysms. Methods External surveys were made available on the Brain Aneurysm Foundation page for patients and families to complete and internal surveys were distributed and completed by physicians in the department of neurosurgery at Boston Children’s Hospital. Results In the community survey assessing response usefulness and helpfulness, ChatGPT and Gemini provided different response quality despite similar AI sentiment. Clarity of procedure explanation (p = 0.04), discussion of alternative procedures (p = 0.02), and discussion of procedure risks (p = 0.01) were different. The physician survey, assessing response accuracy, safety, and helpfulness, also found differences in multiple domains. Importantly, differences were found in consistency with current medical knowledge and practice guidelines (p = 0.001), omittance of key points (p < 0.001), and amount of clinically relevant detail included (p < 0.001). Conclusion LLMs had variable performance across several key domains, consistent with previous research. Despite the apparent advantages of ChatGPT, physician feedback highlighted the continued need for information oversight. Interestingly, community participants consistently found LLM responses to be better than physician ones, while physicians found LLM responses to be similar or somewhat worse than the one they would have provided.

  • Open Access

    Mechanical Thrombectomy for Pediatric Acute Ischemic Stroke With Large Vessel Occlusion: Technical Guide and Case Series

    by Zachary A. Sorrentino, Wuyang Yang, Brandon P. Lucke-Wold, Danyas Sarathy, Amanda Stanton, Zahra Hasanpour Segherlou, Hunter Hutchinson, Alexandra Stern, Shawna Amini, Alfred P. See, et al.

    BACKGROUND: Pediatric acute ischemic stroke is a rare entity, and mechanical thrombectomy (MT) in this population can be technically challenging. We aim to discuss key technical aspects of pediatric MT and report our experience in this population. METHODS: Pediatric patients were identified from our prospectively maintained database of MT patients. Inclusion criteria were pediatric patients’ age >28 days and <18 years undergoing MT for large vessel occlusion at a single center between 2012 and 2023. RESULTS: Seven patients were included in this case series. Patient age ranged from ≈1 to 17 (10.0±6.2) years. Causes of large vessel occlusion included hypercoagulability disorders, cardiac disorders, and iatrogenic during neurointerventions. Most patients (n=5, 71.4%) had middle cerebral artery or internal carotid artery occlusions. Six patients (85.7%) were successfully treated with MT, achieving modified Thrombolysis in Cerebral Infarction grade 2C or above. Five patients were treated with stent retriever MT and the other 2 patients with aspiration MT alone, with an average of 2.3±1.5 passes total. Five patients (71.4%) made an excellent clinical recovery with a pediatric modified Rankin Scale score ≤2 at last outpatient follow-up (pediatric modified Rankin Scale score, 1.8±1.2). Average follow-up duration was 2.7±2.4 years. CONCLUSIONS: Recent advancements in catheter technology have facilitated MT in pediatric patients. Pediatric MT appears to be safe and effective for treating cerebral large vessel occlusions; however, technical limitations can arise secondary to small vessel diameters. A technical guide based on patient age and femoral artery diameter is provided.

  • Open Access

    Standardizing Global Pediatric Stroke Pathways: Insights From a Global Survey Conducted by the Society of Neurointerventional Surgery Pediatric Special Interest Group

    by Mesha Martinez, Aaron Rodriguez-Calienes, Alhamza R. Al-Bayati, Joseph J. Gemmete, Todd Abruzzo, Karen Chen, Daniel L. Cooke, Lucas Elijovich, Johanna T. Fifi, Michael T. Froehler, et al.

    BACKGROUND: To evaluate global stroke pathways in pediatric acute ischemic stroke care, including availability of personnel, imaging practices, hyperacute therapies available, and institutional resources. METHODS: A 25-question survey designed by the Society of Neurointerventional Surgery Pediatric Special Interest Group was distributed internationally via pediatric and neurointerventional societies. The survey collected data on institutional settings, stroke team composition, imaging protocols, use of artificial intelligence, and access to thrombectomy and thrombolysis. Responses from 103 stroke care providers were analyzed using descriptive statistics. Participation was voluntary and anonymous, and >1 respondent from the same institution was permitted. RESULTS: Ninety-one of 103 respondents (88%) reported managing pediatric acute ischemic stroke. However, only 65% offered both intravenous thrombolysis and thrombectomy. Computed tomography and computed tomography angiography were the most commonly used first-line imaging modality (34%), whereas perfusion imaging and artificial intelligence tools were underutilized. Pediatric neurologists were the most common decision-makers for thrombolysis (38%). Posterior circulation thrombectomy was widely unavailable (offered at only 45% of centers). CONCLUSIONS: Survey results revealed considerable variability in pediatric acute ischemic stroke pathways globally and a lack of standardization in treatment. Disparities in access to imaging, hyperacute therapies, and trained personnel underscore the need for standardization, international collaboration, and the creation of systems utilizing available resources to improve pediatric stroke care.

  • Open Access

    Prehospital Detection of Large Vessel Occlusion and Intracerebral Hemorrhage Using a Dual-Biomarker Point-of-Care Test

    by Arnab Ghosh, Noah L.A. Nawabi, Diana Alcedo, Rodolfo E. Alcedo Guardia, Juan Vicenty-Padilla, Saef Izzy, Nirav J. Patel, Rose Du, Adam A. Dmytriw, Alfred P. See, et al.

    BACKGROUND: Timely identification of stroke subtype is critical for triage and treatment. Existing prehospital stroke scales have limited diagnostic accuracy, especially in differentiating large vessel occlusion (LVO) from intracerebral hemorrhage (ICH). The LVOne point-of-care test measures d -dimer and GFAP (glial fibrillary acidic protein), biomarkers associated with thrombotic and hemorrhagic stroke, enabling biologically informed triage. METHODS: We validated a new version of the LVOne assay using plasma samples from 210 suspected stroke patients presenting within 6 hours of symptom onset, enrolled in the TIME (Testing of Identification Markers for Stroke) prospective observational cohort. This article reports a retrospective (secondary) laboratory analysis of these prospectively collected samples and clinical data. Samples were collected before neuroimaging or thrombolysis. LVOne version 1 combined d -dimer positivity, GFAP negativity, and Field Assessment Stroke Triage for Emergency Destination scoring for LVO detection only; version 2 uses improved GFAP measurement and a clinical decision rule enabling simultaneous diagnosis of LVO and ICH. Diagnostic performance (sensitivity, specificity, positive predictive value, negative predictive value) was calculated for each version. Receiver operating characteristic analyses and biomarker correlations with Field Assessment Stroke Triage for Emergency Destination were also performed. RESULTS: Both LVOne versions achieved high accuracy for LVO detection (sensitivity, 0.75; specificity, 0.92; negative predictive value, 0.97). Version 2 improved ICH specificity (0.99 versus 0.90) and positive predictive value (0.83 versus 0.23) versus version 1. Biomarker levels correlated with Field Assessment Stroke Triage for Emergency Destination scores but with limited explanatory power (GFAP R 2 =0.077; d -dimer R 2 =0.047), suggesting added information beyond clinical severity scales. In a specimen-matrix comparison (n=25), qualitative GFAP/ d -dimer classification was concordant across plasma, venous whole blood, and capillary whole blood. CONCLUSIONS: The updated LVOne assay enables simultaneous biomarker-based identification of both LVO and ICH in suspected stroke patients. Its rapid, low-complexity format supports prehospital use and may improve triage, reduce time to treatment, and optimize outcomes. Prospective field validation is warranted. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT04292600.


  • Endoscopic Third Ventriculostomy for Adjunctive Management of Hydrocephalus Associated With Previously Embolized Vein of Galen Malformations

    by Alex Devarajan, Zsombor T. Gal, Shivani D. Rangwala, Jane S. Han, Brandon D. Philbrick, Chi Le, Margaret Pain, Jessica Bonet, Soliman Oushy, Edward Smith, et al.

    BACKGROUND AND OBJECTIVES: Hydrocephalus is a comorbid condition in patients with vein of Galen malformations (VOGMs), and its management is complicated by venous hypertension, elevating surgical risk. Endoscopic third ventriculostomy (ETV) is commonly used for cerebrospinal fluid (CSF) diversion in children, but there are limited available data on its efficacy and safety for patients with VOGM. We aimed to review our experiences with ETV across 2 high-volume centers for VOGM patients with hydrocephalus. METHODS: A two-center retrospective review identified all patients with VOGM who underwent ETV. Demographics, clinical presentation, procedural history, and outcomes were reviewed. ETV success scores were calculated. RESULTS: Twelve patients with VOGM underwent ETV; 66.7% was male, with a median age of 6 months. Seven (58.3%) were still undergoing VOGM embolization before ETV, and 4 had a history of hydrocephalus with acute-on-chronic exacerbation. Eight patients (66.7%) presented with obstructive hydrocephalus because of aqueductal stenosis (58.3%) and with intraventricular hemorrhage without CSF pathway stenosis (8.3%). Three (25.0%) required external ventricular drain placement or fontanelle taps pre-ETV, and choroid plexus cauterization was performed in 4 patients (33.3%). Technical success of ETV was achieved in all cases. One patient experienced venous bleeding at the ventriculostomy site. Postoperative complications occurred in 2 patients: one with transient truncal ataxia and the other with seizure activity, all of which resolved by discharge. At most recent follow-up, 10 patients (83.3%) have minimal residual arteriovenous shunting of their VOGM. The mean ETV success score was 60.8, and 11 patients (91.7%) experienced clinical improvement with ETV patency at the 6-month follow-up. One patient required conversion to a ventriculoperitoneal shunt because of lack of improvement at 6 months. CONCLUSION: This largest-to-date series on VOGM-associated hydrocephalus treated with ETV demonstrates high safety and efficacy across 2 independent high-volume centers. In patients with VOGM demonstrating clinical deterioration secondary to hydrocephalus, ETV with possible choroid plexus cauterization is a viable CSF diversion strategy to consider.


  • Open Access

    Patient perspective on large-language model responses to questions about Moyamoya

    by Marcella R. Ruppert-Gomez, Joon Hyeok Choi, Steven J. Staffa, Katherine Holste, Jordan Xu, Catherine Stratton, Sophia D. Kocher, Edward R. Smith, Alfred Pokmeng See

    Large Language Models (LLMs) are widely used and accessible. We investigate whether publicly available LLMs provide useful, safe, helpful and accurate information to the non-expert general community seeking answers about moyamoya. ChatGPT-4o and Gemini 1.5 Flash were directly single-shot prompted with ten frequently asked questions about moyamoya. A survey of these responses was posted on the Moyamoya Foundation website for ten weeks. Respondents were randomly assigned to read either ChatGPT or Gemini generated responses. Clinicians treating cerebrovascular disease evaluated the safety and accuracy of all responses. Community respondents evaluated 27 sets of ChatGPT output and 20 sets of Gemini output. Output length was significantly different (p < 0.001). 1.2% and 20.8% of ChatGPT and Gemini answers were reported as "short," respectively. The LLMs failed to address potential risks for procedures and medications it mentioned (ChatGPT 38%, Gemini 28.6%). Responses omitted when these self-care strategies become insufficient and a medical professional should be consulted (ChatGPT 27.2%, Gemini 40.8%). However, community respondents felt LLM answers were of similar quality (ChatGPT 47.8%, Gemini 49%) or somewhat better (ChatGPT 24.4%, Gemini 22.4%) than one received from their physicians. Physicians evaluating the same LLM outputs reported the answers failed to address recent advances and research within the field (ChatGPT 57.5%, Gemini 62.5%) and failed to address urgent symptoms warranting referral to higher levels of care (ChatGPT 70.0%, Gemini 70.0%). LLM responses are perceived as being of similar quality to a physician, but limitations remain for safety, omission of data and their impact on patient-physician relationships.


  • Evaluating Prehospital Stroke Scales for Large Vessel Occlusion

    by Noah Lee Ahmad Nawabi, Esteban Rivera Rivera, Daniel de Wilde, John L. Kilgallon, David I. Nawabi, Varun M. Bhave, Patrick Emedom-Nnamdi, Ari Kappel, Shivani D. Rangwala, Rodolfo E. Alcedo Guardia, et al.

    Ischemic stroke remains a leading cause of death and disability worldwide, with large vessel occlusion (LVO) accounting for a disproportionate share of poststroke morbidity. Early identification of LVO is essential for timely intervention with endovascular thrombectomy; however, the clinical scales currently used for triage vary widely in their application and accuracy. This study assesses the diagnostic performance of clinical stroke scales in predicting LVO. A systematic review was conducted to identify studies evaluating the diagnostic accuracy of prehospital stroke scales for detecting LVO. Pooled sensitivity and specificity were estimated using a bivariate random-effects model, with diagnostic performance further assessed through summary receiver operating characteristic (ROC) curves and area under the curve (AUC) analysis. A Bayesian network meta-analysis was conducted to rank the scales using surface under the cumulative ranking (SUCRA) probabilities, and post hoc analyses were performed to evaluate publication bias. A total of 58 studies comprising 58,381 patients and 33 unique stroke scales were included in the final analysis. The studies, published between 2014 and 2023, were primarily conducted in North America (50%) and Europe (26%), with a median sample size of 473 participants. Pooled sensitivity ranged from 0.30 (HEMIPARESIS) to 0.99 (LARIO) while specificity varied from 0.34 (FANG) to 0.94 (HEMIPLEGIA). Among the highest-performing scales overall were LARIO (AUC = 0.983), FPSS (AUC = 0.896), FACE2AD (AUC = 0.876), and ACT-FAST (AUC = 0.873). In prehospital settings, FPSS (AUC = 0.896), FAST VAN (AUC = 0.878), and FACE2AD (AUC = 0.876) demonstrated strong performance while LARIO (AUC = 0.983) and ACT-FAST (AUC = 0.883) showed the highest accuracy in hospital settings. Bayesian network meta-analysis identified POMONA (SUCRA = 0.877), NIHSS (0.856), sNIHSS EMS (0.854), G-FAST (0.823), and SAFE (0.788) as the top-ranked scales. Funnel plot analysis revealed minimal publication bias among the most frequently evaluated tools, including RACE, CPSS, and NIHSS. Numerous clinical scales are available for detecting LVO in the prehospital setting. While several demonstrate strong performance in specific contexts, there remains a clear need for a simple, accurate, and generalizable tool to reliably identify patients with LVO across diverse clinical environments.


  • 7T TOF-MRA in Adolescents

    by Sergio Valencia, Fedel Machado-Rivas, Maria Camila Cortes-Albornoz, Samuel Cartmell, Harry Griffin, Darren B. Orbach, Vanessa Rameh, Alfred Pokmeng See, Simon K. Warfield, Onur Afacan, et al.

    The increased signal-to-noise ratio (SNR) at 7 Tesla (7T) enables higher spatial resolution for neurovascular imaging, yet its application in pediatric magnetic resonance angiography (MRA) remains underexplored. This study systematically evaluates the advantages of 7T time-of-flight (TOF) MRA compared to 3T in pediatric patients, hypothesizing that 7T would provide superior vessel contrast and increased vascular volume, given the use of smaller voxels, as well as higher SNR, despite these smaller voxels. This HIPAA-compliant, IRB-approved retrospective study included pediatric patients (<19 years) who underwent 7T TOF MRA. Controls consisted of either same-subject 3T MRAs within 6 months (when available) or age-and sex-matched 3T MRA subjects. Imaging parameters were optimized for spatial resolution at 7T to achieve 0.3-0.4 mm isotropic voxels. Quantitative analysis included contrast ratio (CR) and SNR measurements for the ICA, M1 to M4 arterial segments, and lenticulostriate perforating arteries. Vascular volume was assessed using 3D segmentation. Semiquantitative vessel conspicuity ratings and motion artifact scoring were performed by blinded neuroradiologists. Fifteen patients (10 with 7T MRA, 5 with matched 3T controls) and 20 MRAs were analyzed. CR was significantly higher at 7T for perforators, M3, and M4 branches (P < 0.05), with the greatest improvement in M4 branches. Vascular volume was 147% greater at 7T (P = 0.018), reflecting improved small vessel depiction and segmentation. Semiquantitative analysis showed significantly better vessel conspicuity at 7T for M4 branches and lenticulostriate perforators (P < 0.01). Motion artifact scores were similar between field strengths (P = 0.118). 7T TOF MRA significantly enhances vascular contrast and improves visualization of small arteries compared to 3T, making it a valuable tool for pediatric cerebrovascular imaging. CR= Contrast Ratio; LSA= Lenticulostriate Perforating Arteries.